Evaluate the Safety, Immunologic, and Virologic Responses of Donor Derived (DD) HIV-Specific T-cells (HST) in HIV-infected Individuals Following Allogeneic Bone Marrow Transplantation (alloRESIST)
Clinical trial NCT04248192 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04248192
- Sponsor
- Catherine Bollard
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-01
- Primary completion
- 2026-11-01
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.